These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20556864)

  • 1. Computational approaches for drug repositioning and combination therapy design.
    Kotelnikova E; Yuryev A; Mazo I; Daraselia N
    J Bioinform Comput Biol; 2010 Jun; 8(3):593-606. PubMed ID: 20556864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
    Lee H; Kang S; Kim W
    PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
    Zhang L; Wang H; Ding K; Xu J
    Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.
    Chen WL; Turlova E; Sun CL; Kim JS; Huang S; Zhong X; Guan YY; Wang GL; Rutka JT; Feng ZP; Sun HS
    Mar Drugs; 2015 Apr; 13(4):2505-25. PubMed ID: 25913706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.
    Hosokawa Y; Takahashi H; Inoue A; Kawabe Y; Funahashi Y; Kameda K; Sugimoto K; Yano H; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
    Biochim Biophys Acta; 2015 Jun; 1850(6):1197-205. PubMed ID: 25644290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
    Wardak Z; Choe KS
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis Suggests Drug Combos for Glioblastoma.
    Cancer Discov; 2016 Jun; 6(6):OF2. PubMed ID: 27165727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
    Bastien JI; McNeill KA; Fine HA
    Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.
    Rao RD; Uhm JH; Krishnan S; James CD
    Front Biosci; 2003 May; 8():e270-80. PubMed ID: 12700121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal control strategies of eradicating invisible glioblastoma cells after conventional surgery.
    de Los Reyes V AA; Jung E; Kim Y
    J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25833239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
    Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
    Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
    Ho KH; Chang CK; Chen PH; Wang YJ; Chang WC; Chen KC
    J Neurochem; 2018 Aug; 146(3):269-288. PubMed ID: 29747239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
    Netland IA; Førde HE; Sleire L; Leiss L; Rahman MA; Skeie BS; Gjerde CH; Enger PØ; Goplen D
    BMC Cancer; 2016 Aug; 16():657. PubMed ID: 27542970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
    Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
    Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
    Daher A; de Groot J
    Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.